» Articles » PMID: 39502329

Synthetic Injectable and Porous Hydrogels for the Formation of Skeletal Muscle Fibers: Novel Perspectives for the Acellular Repair of Substantial Volumetric Muscle Loss

Overview
Journal J Tissue Eng
Date 2024 Nov 6
PMID 39502329
Authors
Affiliations
Soon will be listed here.
Abstract

In severe skeletal muscle damage, muscle tissue regeneration process has to face the loss of resident muscle stem cells (MuSCs) and the lack of connective tissue necessary to guide the regeneration process. Biocompatible and standardized 3D structures that can be injected to the muscle injury site, conforming to the defect shape while actively guiding the repair process, holds great promise for skeletal muscle tissue regeneration. In this study, we explore the use of an injectable and porous lysine dendrimer/polyethylene glycol (DGL/PEG) hydrogel as an acellular support for skeletal muscle regeneration. We adjusted the DGL/PEG composition to achieve a stiffness conducive to the attachment and proliferation of murine immortalized myoblasts and human primary muscle stems cells, sustaining the formation and maturation of muscle fibers . We then evaluated the potential of one selected "myogenic-porous hydrogel" as a supportive structure for muscle repair in a large muscle defect in rats. This injectable and porous formulation filled the defect, promoting rapid cellularization with the presence of endothelial cells, macrophages, and myoblasts, thereby supporting neo-myogenesis more specifically at the interface between the wound edges and the hydrogel. The selected porous DGL/PEG hydrogel acted as a guiding scaffold at the periphery of the defect, facilitating the formation and anchorage of aligned muscle fibers 21 days after injury. Overall, our results indicate DGL/PEG porous injectable hydrogel potential to create a pro-regenerative environment for muscle cells after large skeletal muscle injuries, paving the way for acellular treatment in regenerative muscle medicine.

References
1.
Shansky J, Del Tatto M, Chromiak J, Vandenburgh H . A simplified method for tissue engineering skeletal muscle organoids in vitro. In Vitro Cell Dev Biol Anim. 1997; 33(9):659-61. DOI: 10.1007/s11626-997-0118-y. View

2.
COOPER R, Tajbakhsh S, Mouly V, Cossu G, Buckingham M, Butler-Browne G . In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle. J Cell Sci. 1999; 112 ( Pt 17):2895-901. DOI: 10.1242/jcs.112.17.2895. View

3.
Chen C, Wei S, Chen W, Hsu T, Chen Y . Reconstructing vascular networks promotes the repair of skeletal muscle following volumetric muscle loss by pre-vascularized tissue constructs. J Tissue Eng. 2023; 14:20417314231201231. PMC: 10517612. DOI: 10.1177/20417314231201231. View

4.
Eugenis I, Wu D, Rando T . Cells, scaffolds, and bioactive factors: Engineering strategies for improving regeneration following volumetric muscle loss. Biomaterials. 2021; 278:121173. PMC: 8556323. DOI: 10.1016/j.biomaterials.2021.121173. View

5.
Aurora A, Roe J, Corona B, Walters T . An acellular biologic scaffold does not regenerate appreciable de novo muscle tissue in rat models of volumetric muscle loss injury. Biomaterials. 2015; 67:393-407. DOI: 10.1016/j.biomaterials.2015.07.040. View